You have taken your daily gout pill for a year, the painful flares have stopped, and your joints feel normal again. It is a fair question to ask whether you still need the medicine. A Dutch trial presented at the EULAR 2026 congress in early June is among the first randomized studies to test that exact question, and its answer is worth knowing before anyone changes a prescription. This article explains what the researchers did, what they found, and how your uric acid blood test fits in. It does not replace advice from the clinician who prescribed your treatment.
What the 2026 trial actually tested
According to the EMJ report from the congress, researchers at nine rheumatology clinics in the Netherlands enrolled 309 people with gout whose disease had been quiet for a while. Half kept taking urate-lowering medicine, with the dose adjusted until blood uric acid stayed under a set target. The other half tried to stop, with the option to restart if flares came back. Everyone was followed for 24 months.
Urate-lowering therapy means a daily medicine, most often allopurinol, that reduces the uric acid in your blood so that crystals can dissolve out of the joints. It is different from the pills used to calm a flare once it has started. The trial design was published in advance in the journal Trials, which makes the comparison more reliable than a look back at patient records.
What the numbers showed
The two groups ended up in clearly different places, as the table below shows. Remission was measured over the last six months of the study, and flare rates cover the full two years.
| Outcome over 24 months | Kept taking medicine | Tried stopping |
|---|---|---|
| In remission during the last 6 months | 79.2% | 62.9% |
| Cumulative flare incidence | 12.3% | 31.8% |
| Restarted medicine | Не е приложимо | 23% (median about 13 months) |
In plain terms, people who stopped had roughly two and a half times as many flares, and more of them needed anti-inflammatory drugs. Some did well without medicine, and about three in four never restarted, but the safer course for the group as a whole was to keep going.
How to read these results
The trial was open label, meaning patients and doctors knew who was in which group, and it lasted two years, so longer-term effects remain unknown. The investigators also noted that it is still unclear who can stop safely, and cost was not assessed. The results were presented at a congress, and we have not seen the full peer-reviewed paper. The lead commentator said the findings support current recommendations to continue treatment during remission at the population level.
What this changes for you is practical. Feeling well on treatment is usually a sign the medicine is working, not a sign you no longer need it. If you are tempted to stop, raise it with your prescriber first, because a supervised plan can include closer monitoring and a clear path to restart.
Where your uric acid blood test fits in
Guidelines from the American College of Rheumatology recommend a treat-to-target approach, which means adjusting the dose until blood uric acid is below 6 mg/dL. MedlinePlus gives the same goal and notes that a lower target applies when visible deposits called tophi are present. Your result on treatment tells you whether the dose is doing its job. If you want the basics, our guide explains how to read a uric acid blood test.
A normal result while you take the medicine does not mean gout has gone away. It means the medicine is holding uric acid below the level where crystals form. For flare care and day-to-day management, see our guide to gout pain relief and long-term control.
Последни научни постижения
Several recent studies add context to the stop-or-continue question. They come from PubMed, and most are small or preliminary, so they inform the conversation without settling it.
Starting low may mean fewer flares
A randomized trial in China published in September 2026 compared two very low starting doses of febuxostat in 120 men. Both groups reached their uric acid target by the end, but the group that started lower had clearly fewer flares along the way. It was a single-country study in men only, so it needs confirmation. For you, it supports a familiar principle: new gout treatment usually starts gently and increases step by step.
Blood pressure pills can nudge uric acid
A 2026 meta-analysis found that losartan, a common blood pressure medicine, lowers uric acid slightly compared with placebo. The effect is modest and losartan is not a gout treatment. It matters mainly because some other blood pressure drugs, such as diuretics, can raise uric acid, so your full medication list is worth reviewing.
Kidneys and heart are separate questions
A 2026 systematic review found that lowering uric acid did not consistently slow kidney decline, and a separate review concluded that routine treatment for heart protection is not supported when there are no gout symptoms. In other words, these medicines are for gout, and people with kidney concerns can track them with the панел за бъбречна функция.
Кога да се обърнете към лекар
- You are considering stopping or reducing your gout medicine for any reason.
- A flare returns while you are on treatment, or your joint pain changes.
- You develop a rash, fever or mouth sores after starting a new gout medicine, which needs urgent care.
- You have not had a uric acid blood test in the past year.
- You have new swelling, hard lumps near joints, or kidney symptoms such as flank pain.
Речник
- Urate-lowering therapy: daily medicine that reduces uric acid in the blood over the long term.
- Treat-to-target: adjusting the dose until a blood uric acid goal is reached and kept.
- Remission: a period with no flares and no active joint deposits, assessed by criteria set by rheumatologists.
- Tophi: hard lumps of uric acid crystals under the skin near joints.
- Serum urate: the amount of uric acid in a blood sample, also called uric acid level.
Често задавани въпроси
Can I stop allopurinol if I have had no flares for a year? The 2026 trial suggests most people do better if they continue, though some can stop. Decide with your prescriber, not on your own.
How long do you take gout medicine? Guidelines generally describe long-term treatment, because stopping lets uric acid rise again. Your clinician will tailor the plan.
What uric acid level should I aim for? The usual goal is below 6 mg/dL, and lower if you have tophi, according to the American College of Rheumatology and MedlinePlus.
Why do flares happen when treatment begins? As uric acid falls, crystals start to dissolve and can trigger inflammation. That is why doctors often add a preventive anti-inflammatory for the first months.
Does a normal uric acid result mean I am cured? No. It means the medicine is working. Gout is managed, not cured.
Източници
- EMJ: New Insights in Gout Management, EULAR 2026 (June 3, 2026)
- American College of Rheumatology: 2020 Gout Management Guideline
- MedlinePlus (NIH): Gout
- PubMed: Peeters et al., GO TEST Finale trial protocol, Trials 2023
- PubMed: Ultra-low starting dose febuxostat titration in male patients with primary gout, Int J Rheum Dis 2026
- PubMed: Urate-lowering effects of losartan: meta-analysis, Hypertens Res 2026
- PubMed: Serum uric acid in chronic kidney disease: systematic review, Cureus 2026
- PubMed: Urate-lowering therapy in cardiovascular pharmacotherapy, Eur Heart J Cardiovasc Pharmacother 2026
Други статии
- Gout pain relief: flare care and lasting control
- Uric acid test: what your results mean
- Arthritis: types, symptoms, causes and lab tests
Разбери резултатите от собствените си кръвни изследвания с AI DiagMe
Have a uric acid result and not sure what it means for your treatment? Разберете резултатите от изследванията си с AI DiagMe, our AI reviewed by a committee of physicians.
